Early Access — free while we kick the tires
EdgarHawk

Kline Loni N.

EVP/Chief Growth Officer

Officer
2 filings analyzed · 1 company · Latest 2026-03-09

Companies

Company Buys Sells Direction
MUNCY COLUMBIA FINANCIAL Corp CCFN 2 0 Net buying

Activity

March 2026
medium
Buy
312 shares
$19,297
Significance 4/10

EVP Loni Kline purchases 312 CCFN shares ($19.3K) on 2026-03-06, raising holdings 62.7% to 810 shares

Loni Kline, EVP/Chief Growth Officer, purchased 312 shares at $61.85 on 2026-03-06, increasing his holdings from 498 to 810 shares—a 62.7% increase in position size. The buy occurred at $61.85, significantly above the current price of $20.62, placing the transaction well above the current trading level. This represents his second open-market purchase at CCFN within two consecutive days (having also bought 30 shares on 2026-03-05). The stock's fundamentals show a P/E of 2.67 on net income of $6,719,000.00 with a market cap of $72,927,867.48, while price action over the past 90 days has been positive at +14.6%.

Buy
498 shares
$30,801
Significance 4/10

EVP/Chief Growth Officer Loni N. Kline buys 498 shares at $61.85; stock now $20.62, 52-week high $20.93

Kline Loni N., EVP/Chief Growth Officer, purchased 498 shares at $61.85 for a total value of $30,801.30, representing an initial equity stake in CCFN. The current market price of $20.62 is materially below the transaction price, indicating an unrealized loss on the position. The stock is currently trading at -1.5% from its 52-week high of $20.93, with modest recent momentum (up 14.6% over 90 days and +1.8% over 30 days), though this recovery has not yet approached the entry price. The company's fundamentals show a lean valuation at P/E 2.67 with a $72.9M market cap and $6.7M net income, but the temporal gap between the purchase date (2026-03-05) and current market levels suggests either market conditions have shifted or the insider's timing assumption did not materialize as anticipated.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access